Reduced VDAC1 protects against Alzheimer's disease, mitochondria, and synaptic deficiencies.
about
Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Diseasep53 and mitochondrial dysfunction: novel insight of neurodegenerative diseasesMemory and hippocampal architecture following short-term midazolam in western diet-treated rats.Mitochondria in Alzheimer's Disease and Diabetes-Associated Neurodegeneration: License to Heal!Mitochondrial VDAC1: A Key Gatekeeper as Potential Therapeutic TargetTranscriptional evidence for the role of chronic venlafaxine treatment in neurotrophic signaling and neuroplasticity including also Glutamatergic [corrected] - and insulin-mediated neuronal processes.Synergistic exacerbation of mitochondrial and synaptic dysfunction and resultant learning and memory deficit in a mouse model of diabetic Alzheimer's disease.Mitochondrial and cytoskeletal alterations are involved in the pathogenesis of hydronephrosis in ICR/Mlac-hydro miceMolecular Targets of Cannabidiol in Neurological DisordersMicroRNA-7 Regulates the Function of Mitochondrial Permeability Transition Pore by Targeting VDAC1 Expression.Mitochondria and Synaptic Plasticity in the Mature and Aging Nervous System.On the Pathogenesis of Alzheimer's Disease: The MAM Hypothesis.Novel function of ceramide for regulation of mitochondrial ATP release in astrocytes.A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease.Direct Structural Annotation of Membrane Protein Aggregation Loci using Peptide-Based Reverse Mapping.
P2860
Q26801929-AA316AC4-E3F2-4751-8CA3-AB6A06657C1CQ28076425-7B3EC1CF-5FD8-40FE-9F2A-65FD873C1911Q31077590-B58DC5B9-BE8E-49A9-A20C-816AB7A8C3D4Q33364882-414BE601-97F5-4BC0-8D0E-0BAADED66ADDQ33854939-3E0E32C6-9DA4-48D6-AACA-C8F368514F23Q34571919-6036901E-23C6-4FDE-9EA6-95038898377DQ35738734-5693E6BA-A29D-4D49-81AB-5872389F20AAQ35958998-9038F9CF-5A98-4B01-BC40-0F3047AE5CFDQ36157649-5BEC8BF6-17F6-4C3B-8B9D-C0D837DAA7CEQ36744745-A0278B59-2A4B-493C-9484-FED02D00CD39Q38807556-105A0DB1-E241-4079-AF2B-EA4B8711F9E6Q39155255-97CA4B87-3A72-43E6-B27F-50788E33F22AQ47872027-C46F9076-4B6D-4819-924C-CED6E6EEA495Q51737097-C938C55C-9430-40E1-9966-E4C829E22A7BQ55361015-83622986-E2C6-4332-B10A-E07618CCDA01
P2860
Reduced VDAC1 protects against Alzheimer's disease, mitochondria, and synaptic deficiencies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reduced VDAC1 protects against ...... ia, and synaptic deficiencies.
@en
Reduced VDAC1 protects against ...... ia, and synaptic deficiencies.
@nl
type
label
Reduced VDAC1 protects against ...... ia, and synaptic deficiencies.
@en
Reduced VDAC1 protects against ...... ia, and synaptic deficiencies.
@nl
prefLabel
Reduced VDAC1 protects against ...... ia, and synaptic deficiencies.
@en
Reduced VDAC1 protects against ...... ia, and synaptic deficiencies.
@nl
P2093
P2860
P356
P1476
Reduced VDAC1 protects against ...... ia, and synaptic deficiencies.
@en
P2093
Maria Manczak
P Hemachandra Reddy
Tatiana Sheiko
William J Craigen
P2860
P304
P356
10.3233/JAD-130761
P577
2013-01-01T00:00:00Z